HIV-1 fitness and macrophages

被引:16
作者
Goodenow, MM
Rose, SL
Tuttle, DL
Sleasman, JW
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Pediat, Div Immunol & Infect Dis, Gainesville, FL 32610 USA
[3] Univ S Florida, Coll Med, Dept Pediat, Div Allergy & Immunol, St Petersburg, FL 33701 USA
[4] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA
关键词
review; antiretroviral therapy; gag/protease; envelope; tropism; phenotype;
D O I
10.1189/jlb.0403186
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
HIV-1 comprises a collection of closely related, but not identical, viruses or quasispecies. Fitness represents a selective advantage for propagation among populations of organisms competing in a particular environment and is an important characteristic of viruses because of a link between fitness and pathogenesis. Environmental differences based on the type of cell that is targeted for infection or the cell type that produces virus, impact fitness. CD4-expressing cells of lymphocyte or macrophage lineage are the principal host cells for HIV-1, although the milieu in lymphocytes is distinct from the macrophage environment from the perspective of cell half-life and activation, signal transduction and expression of coreceptors, and bioavailability of antiretroviral. drugs. Multiple viral determinants, including entry via envelope glycoproteins, replication by reverse transcriptase, and virion maturation by protease activity, contribute to fitness in different cells and provide targets for current antiretroviral therapies. This review focuses on fitness of HIV-1 in macrophages and examines the impact of protease inhibitors on fitness of quasispecies and an unexplained discordance between fitness and pathogenesis. J. Leukoc. Biol. 74: 657-666; 2003.
引用
收藏
页码:657 / 666
页数:10
相关论文
共 156 条
[21]   HIV-1 receptors and cell tropism [J].
Clapham, PR ;
McKnight, A .
BRITISH MEDICAL BULLETIN, 2001, 58 :43-59
[22]  
Clavel F, 2000, Adv Pharmacol, V49, P41
[23]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[24]   THE KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTION ARE SLOWER IN PRIMARY HUMAN MACROPHAGES THAN IN A LYMPHOID-CELL LINE [J].
COLLIN, M ;
GORDON, S .
VIROLOGY, 1994, 200 (01) :114-120
[25]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[26]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[27]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[28]   Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir [J].
Côté, HCF ;
Brumme, ZL ;
Harrigan, PR .
JOURNAL OF VIROLOGY, 2001, 75 (02) :589-594
[29]   Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors [J].
Croteau, G ;
Doyon, L ;
Thibeault, D ;
McKercher, G ;
Pilote, L ;
Lamarre, D .
JOURNAL OF VIROLOGY, 1997, 71 (02) :1089-1096
[30]   Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection [J].
Crowe, SM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (06) :777-783